Publications by authors named "Dr Utku Limon"
Semin Ophthalmol
August 2024
Article Synopsis
- The study aimed to assess how different patterns of diabetic macular edema (DME) respond to intravitreal injection therapies, particularly ranibizumab and aflibercept, over a 12-month period.
- Participants were categorized into four groups based on their OCT features, and their visual acuity and central macular thickness were measured at baseline and after 3, 6, and 12 months.
- Results showed no significant differences in visual acuity improvement or the number of injections needed among the groups, but group 4 had the highest baseline central macular thickness and the most significant reduction in thickness by month 12.
